fashion -WSS

fashion

author：knowledge 2025-09-27 16:50:08 - browse：4

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Life science postdocs should get big pay hike, NIH panel says

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

International team creates first chimeric human

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Physician assistants need a new name. Here's what it should be

How to address the problem of discarded donor organs

Biotech companies concerned about China biosecurity crackdown

leisure time

fashion

explore

In Memoriam: Notable people who died in 2023

Medicare Advantage coverage denials need scrutiny, senators say

Cancer drug shortages should be causing more outrage

Allen Institute goes after foundational questions, CEO Costa says

Wildfire smoke exposes gaps in outdoor worker protections

Covid isolation guidance eased by the CDC

Alkermes shareholders re

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Cancer drug shortages should be causing more outrage

A Q&A with Aletha Maybank, AMA’s chief health equity officer

focus

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Gene therapy denied for Afghan refugee whose father aided U.S.

Boston Scientific acquires urology company Axonics for $3.7 billion

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Male doctors called my cancer incurable. A female doctor showed it wasn't

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

explore

explore

focus